Stimmrechtsanteile: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] wi.


11.01.19 10:50
Meldung
 

DGAP Voting Rights Announcement: Epigenomics AG
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

11.01.2019 / 10:47
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

<Details of issuer
Name: Epigenomics AG
Street: Geneststraße 5
Postal code: 10829
City: Berlin
Germany
Legal Entity Identifier (LEI): 549300X1C4U862NDLN97

2. Reason for notification
X Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
  Other reason:

3. Details of person subject to the notification obligation
Legal entity: Morgan Stanley
City of registered office, country: Wilmington, Delaware, United States of America (USA)

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
 

5. Date on which threshold was crossed or reached:
03 Jan 2019

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
Total of both in %
(7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New 2.78 % 0.13 % 2.91 % 36021540
Previous notification 3.75 % 0.13 % 3.88 % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
DE000A11QW50 0 1002882 0.00 % 2.78 %
Total 1002882 2.78 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
Right of recall over securities lending agreements at any time at any time 45919 0.13 %
    Total 45919 0.13 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
0 0.00 %
      Total 0 0.00 %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
Morgan Stanley % % %
Morgan Stanley Capital Management, LLC % % %
Morgan Stanley Domestic Holdings, Inc. % % %
Morgan Stanley & Co. LLC % % %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
 

Date
09 Jan 2019



11.01.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Epigenomics AG
Geneststraße 5
10829 Berlin
Germany
Internet: www.epigenomics.com

 
End of News DGAP News Service

765339  11.01.2019 

fncls.ssp?fn=show_t_gif&application_id=765339&application_name=news&site_id=ariva


 

Breaking News


Kurs- und weitere Informationen zum Thema:

Epigenomics

Aktuelle Diskussionen zum Thema:

Epigenomics auf dem Weg zur ... (06.07.20)
EPI Übernahme - Wir halten ... (06.07.20)
CMS (02.03.20)

Aktuelle Nachrichten zum Unternehmen:

Epigenomics: Was kann da noch k. (03.07.20)
Epigenomics: Meinungen? (26.06.20)
Epigenomics: Es hat sich bereits a. (01.06.20)
Epigenomics: US-News lockt Käufe. (24.04.20)
Epigenomics: Das wird für Rücken. (14.04.20)

Alle Nachrichten zum Unternehmen

Aktuelle Analysen zu den Unternehmen:

Epigenomics
Weitere Meldungen
 
11.01 Stimmrechtsanteile: Bayer A.
11.01 Stimmrechtsanteile: Heidelber.
11.01 Directors' Dealings: InCity Im.
11.01 ZEAL receives indicative of.
11.01 Finanzbericht: PATRIZIA Imm.
11.01 Stimmrechtsanteile: Eckert &.
11.01 Stimmrechtsanteile: Epigenom.
11.01 EYEMAXX Real Estate AG.
11.01 Stimmrechtsanteile: Epigenom.
11.01 Finanzbericht: PATRIZIA Imm.
11.01 VALORA EFFEKTEN HAN.
11.01 Intershop steigert Cloud-Auf.
11.01 Stimmrechtsanteile: aap Impla.
11.01 Stimmrechtsanteile: Allianz S.
11.01 Stimmrechtsanteile: Münchene.
11.01 Zulassungsfolgepflichten: Zal.
11.01 Directors' Dealings: EYEMAX.
11.01 Benchmark Expands the Pho.
11.01 youmex übernimmt LUNIS V.
11.01 Deutsche Industrie REIT-AG.
11.01 Nordex Group unterzeichnet .
11.01 HELLA steigert Umsatz und.
11.01 TLG IMMOBILIEN meldet Vo.
11.01 Ammbr's Technologies Selec.
10.01 Argo Gold Announces Closin.
10.01 AKASOL AG: Carsten Bove.
10.01 Goldsource Mines Announces.
10.01 Stimmrechtsanteile: Deutsche.
10.01 Stimmrechtsanteile: Deutsche.
10.01 EQS-News: Report on Swiss.


Umfrage
 
Welche Social Networks nutzen Sie meistens?
Facebook
keine
Twitter
Xing
Linked in
Youtube
myspace
Google+
Wikipedia
andere


Stimmen: 64961 , Ergebnis


Kurssuche
Status: nicht eingeloggt

Registrieren | Passwort vergessen?
 
 
Im Bereich Nachrichten:
Silber: Jetzt geht die Post ab!
Experte: Stefan Hofmann, STOCK-WORLD
Kolumnen
De Grey Mining: Top-...
Björn Junker, GOLDINVEST.de (12:26)
Experte: Björn Junker, GOLDINVEST.de
Steinhoff Aktie: Verkauf ...
Volker Gelfarth, (12:16)
Experte: Volker Gelfarth,
Bundes-/Staatsanleihen
Börse Stuttgart AG, (12:08)
Experte: Börse Stuttgart AG,
Corona – Was interessiert ...
Feingold-Research, (11:44)
Experte: Feingold-Research,
Bechtle-Aktie – Sehr sehr ...
Robert Sasse, (11:31)
Experte: Robert Sasse,
Experten-Interview: "Bitcoin ...
Stock-World Redaktion, STOCK-WORLD (11:18)
Experte: Stock-World Redaktion, STOCK-WORLD
Silber: Jetzt geht die Post ...
Stefan Hofmann, STOCK-WORLD (11:11)
Experte: Stefan Hofmann, STOCK-WORLD
Aurubis - Aufwärtstrend ...
Christian Zoller, www.boerse-daily.de (11:00)
Experte: Christian Zoller, www.boerse-daily.de
ETFs: Tech-ETFs als die ...
Redaktion boerse-frankf., Deutsche Börse AG (10:38)
Experte: Redaktion boerse-frankfurt.de, Deutsche Börse AG
Chancen der Royalty-...
Ingrid Heinritzi, (10:21)
Experte: Ingrid Heinritzi,
Wenn an den Börsen aus ...
Sven Weisenhaus, Stockstreet GmbH (09:51)
Experte: Sven Weisenhaus, Stockstreet GmbH
DAX hält die 12.500er ...
CMC Markets, (09:31)
Experte: CMC Markets,
Niquet's World
Neues vom Portal
 
Mit Sportwetten Geld verdienen - möglich oder unrealistisch?
Letzte Börsen-Meldung
 
Letzte Börsen-Analyse
 
Top-Klicks News
 
Top-Klicks Analysen